SUVRETTA CAPITAL MANAGEMENT, LLC (CIK 1569064) reported 39 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-02-09). Recent activity: Buy MANE (3,178 shares), Buy MANE (19,338 shares), Buy MANE (14,659 shares), Buy MANE (53,344 shares), Buy MANE (25,908 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 3,178 | $123,624 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 19,338 | $706,804 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 14,659 | $531,682 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 53,344 | $2.0M |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 25,908 | $986,836 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 18,489 | $719,222 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 1,720 | $58,910 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 10,676 | $370,884 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 2,519 | $91,364 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 9,168 | $340,224 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 4,453 | $169,615 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 10,004 | $342,637 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 3,832 | $138,220 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 19,199 | $709,019 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 38,771 | $1.5M |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 17,835 | $689,679 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 16,563 | $659,207 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 11,183 | $402,253 |
| 2026-02-09 | Veradermics, Inc (MANE) | Director | Buy | 1,835 | $63,748 |
| 2025-12-29 | Benitec Biopharma Inc. (BNTC) | Director | Buy | 11,587 | $155,729 |
| 2025-12-29 | Benitec Biopharma Inc. (BNTC) | Director | Buy | 7,400 | $95,090 |
| 2025-12-29 | Benitec Biopharma Inc. (BNTC) | Director | Buy | 14,320 | $187,592 |
| 2025-12-29 | Benitec Biopharma Inc. (BNTC) | Director | Buy | 2,516 | $32,960 |
| 2025-12-29 | Benitec Biopharma Inc. (BNTC) | Director | Buy | 65,800 | $884,352 |
| 2025-12-29 | Benitec Biopharma Inc. (BNTC) | Director | Buy | 42,600 | $547,410 |
Source: SEC Form 4 filings · as of 2026-02-09